Oral antimicrobial peptides: Types and role in the oral cavity
- PMID: 27752223
- PMCID: PMC5059823
- DOI: 10.1016/j.jsps.2015.02.015
Oral antimicrobial peptides: Types and role in the oral cavity
Abstract
Antimicrobial peptides (AMPs) are a wide-ranging class of host-defense molecules that act early to contest against microbial invasion and challenge. These are small cationic peptides that play an important in the development of innate immunity. In the oral cavity, the AMPs are produced by the salivary glands and the oral epithelium and serve defensive purposes. The aim of this review was to discuss the types and functions of oral AMPs and their role in combating microorganisms and infections in the oral cavity.
Keywords: Antimicrobial peptides (AMPs); Cathelicidins; Defensins; Dental applications; Histatins; Oral cavity.
Figures
Similar articles
-
Potential applications of antimicrobial peptides and their mimics in combating caries and pulpal infections.Acta Biomater. 2017 Feb;49:16-35. doi: 10.1016/j.actbio.2016.11.026. Epub 2016 Nov 11. Acta Biomater. 2017. PMID: 27845274 Review.
-
Susceptibility of periodontopathogenic and cariogenic bacteria to defensins and potential therapeutic use of defensins in oral diseases.Curr Pharm Des. 2007;13(30):3084-95. doi: 10.2174/138161207782110426. Curr Pharm Des. 2007. PMID: 17979751 Review.
-
Functions of Antimicrobial Peptides in Vertebrates.Curr Protein Pept Sci. 2017;18(11):1098-1119. doi: 10.2174/1389203717666160813162629. Curr Protein Pept Sci. 2017. PMID: 27526932 Review.
-
[Physiologic and pathophysiologic significance of antimicrobial (host defensive) small peptides].Orv Hetil. 2008 Dec 21;149(51):2419-24. doi: 10.1556/OH.2008.28511. Orv Hetil. 2008. PMID: 19073453 Review. Hungarian.
-
Important Roles and Potential Uses of Natural and Synthetic Antimicrobial Peptides (AMPs) in Oral Diseases: Cavity, Periodontal Disease, and Thrush.J Funct Biomater. 2022 Oct 3;13(4):175. doi: 10.3390/jfb13040175. J Funct Biomater. 2022. PMID: 36278644 Free PMC article. Review.
Cited by
-
The Multifaceted Histidine-Based Carriers for Nucleic Acid Delivery: Advances and Challenges.Pharmaceutics. 2020 Aug 14;12(8):774. doi: 10.3390/pharmaceutics12080774. Pharmaceutics. 2020. PMID: 32823960 Free PMC article. Review.
-
Host Defence Peptides in Diabetes Mellitus Type 2 Patients with Periodontal Disease. A Systematic Review.Diagnostics (Basel). 2021 Nov 26;11(12):2210. doi: 10.3390/diagnostics11122210. Diagnostics (Basel). 2021. PMID: 34943445 Free PMC article. Review.
-
IκBζ is an essential mediator of immunity to oropharyngeal candidiasis.Cell Host Microbe. 2023 Oct 11;31(10):1700-1713.e4. doi: 10.1016/j.chom.2023.08.016. Epub 2023 Sep 18. Cell Host Microbe. 2023. PMID: 37725983 Free PMC article.
-
Exosomes derived from clinical-grade oral mucosal epithelial cell sheets promote wound healing.J Extracell Vesicles. 2019 Jan 20;8(1):1565264. doi: 10.1080/20013078.2019.1565264. eCollection 2019. J Extracell Vesicles. 2019. PMID: 30719240 Free PMC article.
-
Antimicrobial Peptides with Antibacterial Activity against Vancomycin-Resistant Staphylococcus aureus Strains: Classification, Structures, and Mechanisms of Action.Int J Mol Sci. 2021 Jul 25;22(15):7927. doi: 10.3390/ijms22157927. Int J Mol Sci. 2021. PMID: 34360692 Free PMC article. Review.
References
-
- Abiko Y., Jinbu Y., Noguchi T., Nishimura M., Kusano K., Amaratunga P., Shibata T., Kaku T. Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study. Pathol.-Res. Practice. 2002;198(8):537–542. - PubMed
-
- Abiko Y., Saitoh M., Nishimura M., Yamazaki M., Sawamura D., Kaku T. Role of beta-defensins in oral epithelial health and disease. Med. Mol. Morphol. 2007;40(4):179–184. - PubMed
-
- Adonogianaki E., Moughal N.A., Kinane D.F. Lactoferrin in the gingival crevice as a marker of polymorphonuclear leucocytes in periodontal diseases. J. Clin. Periodontol. 1993;20(1):26–31. - PubMed
-
- Adonogianaki E., Mooney J., Kinane D.F. Detection of stable and active periodontitis sites by clinical assessment and gingival crevicular acute-phase protein levels. J. Periodontal Res. 1996;31(2):135–143. - PubMed
-
- Aguilera O., Andres M.T., Heath J., Fierro J.F., Douglas C.W. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol. Med. Microbiol. 1998;21(1):29–36. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources